Relative Value Partners Group, LLC Eli Lilly & CO Transaction History

Relative Value Partners Group, LLC

  • $751 Million
  • Q2 2024

A detailed history of Relative Value Partners Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Relative Value Partners Group, LLC holds 8,287 shares of LLY stock, worth $6.19 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
8,287
Previous 1,767 368.99%
Holding current value
$6.19 Million
Previous $1.37 Million 446.0%
% of portfolio
1.0%
Previous 0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
BUY
$724.87 - $909.04 $4.73 Million - $5.93 Million
6,520 Added 368.99%
8,287 $7.5 Million
Q1 2024

May 13, 2024
SELL
$592.2 - $792.28 $14,212 - $19,014
-24 Reduced 1.34%
1,767 $1.37 Million
Q4 2023

Feb 12, 2024
BUY
$525.19 - $619.13 $31,511 - $37,147
60 Added 3.47%
1,791 $1.04 Million
Q3 2023

Nov 13, 2023
BUY
$434.7 - $599.3 $236,911 - $326,618
545 Added 45.95%
1,731 $929,000
Q1 2023

May 12, 2023
SELL
$310.63 - $364.82 $182,650 - $214,514
-588 Reduced 33.15%
1,186 $407,000
Q4 2022

Feb 13, 2023
BUY
$321.55 - $374.67 $172,993 - $201,572
538 Added 43.53%
1,774 $649,000
Q3 2022

Nov 10, 2022
BUY
$296.48 - $337.87 $366,449 - $417,607
1,236 New
1,236 $400,000
Q2 2022

Aug 11, 2022
SELL
$278.73 - $327.27 $311,898 - $366,215
-1,119 Closed
0 $0
Q1 2021

May 12, 2021
SELL
$164.32 - $212.72 $213,616 - $276,536
-1,300 Reduced 53.74%
1,119 $209,000
Q4 2020

Feb 12, 2021
BUY
$130.46 - $172.63 $13,306 - $17,608
102 Added 4.4%
2,419 $408,000
Q3 2020

Nov 12, 2020
SELL
$146.22 - $169.13 $14,622 - $16,913
-100 Reduced 4.14%
2,317 $343,000
Q4 2019

Feb 13, 2020
BUY
$106.92 - $132.43 $12,509 - $15,494
117 Added 5.09%
2,417 $318,000
Q3 2019

Nov 14, 2019
BUY
$106.79 - $116.16 $14,950 - $16,262
140 Added 6.48%
2,300 $257,000
Q2 2019

Aug 13, 2019
SELL
$110.79 - $129.32 $14,402 - $16,811
-130 Reduced 5.68%
2,160 $239,000
Q1 2019

May 14, 2019
SELL
$111.31 - $131.02 $23,375 - $27,514
-210 Reduced 8.4%
2,290 $297,000
Q2 2018

Aug 13, 2018
BUY
$75.7 - $86.88 $189,250 - $217,200
2,500 New
2,500 $213,000
Q1 2018

May 11, 2018
SELL
$74.21 - $87.6 $185,524 - $219,000
-2,500 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
2,500
2,500 $206,000

Others Institutions Holding LLY

# of Institutions
4,404
Shares Held
807M
Call Options Held
9.91M
Put Options Held
10.9M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Relative Value Partners Group, LLC Portfolio

Follow Relative Value Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relative Value Partners Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email